IL-12 is a dimeric
cytokine that is produced primarily by APCs. In this study we examined the role that the p38 MAPKs (
MAPK/p38) play in regulating
IL-12 production. We show that inhibition of p38 dramatically increased
IL-12 production upon stimulation, while decreasing TNF-α. This reciprocal effect on these two
cytokines following
MAPK/p38 inhibition occurred in many different APCs, following a variety of different stimuli.
IL-12 production was also increased in macrophages treated with
small interfering RNA to limit p38α expression, and in macrophages deficient in MKK3, a
kinase upstream of p38. The increase in
IL-12 production following
MAPK/p38 inhibition appears to be due to enhanced
IL-12 (p40) mRNA stability. We show that
MAPK/p38 inhibition can promote Th1 immune responses and thereby enhance
vaccine efficacy against
leishmaniasis. In a mouse model of Leishmania major
infection, vaccination with heat-killed L. major plus CpG and
SB203580 elicited complete protection against
infection compared with heat-killed L. major plus CpG without
SB203580. Thus, this work suggests that
MAPK/p38 inhibitors may be applied as adjuvants to bias immune responses and improve vaccinations against intracellular pathogens.